CNS Pharmaceuticals CNSP

$ 0.13 3.44%

Quarterly report 2024-Q3
added 11-14-2024

CNS Pharmaceuticals Financial Statements 2011-2024 | CNSP

Annual Financial Statements CNS Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.32 M	1.54 M	528 K	28.4 M	59.4 M	-	-	-	-	-	-	-	-
Shares	3.77 M	1.36 M	878 K	16.5 M	13.6 M	-	-	-	-	-	-	-	-
Historical Prices	0.35	1.13	0.601	1.72	4.31	-	-	-	-	-	-	-	-
Net Income	-18.9 M	-15.3 M	-14.5 M	-9.46 M	-3.88 M	-7.39 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-18.9 M	-15.3 M	-14.5 M	-9.45 M	-3.83 M	-882 K	-	-	-	-	-	-	-
Interest Expense	13.8 K	7.03 K	9.28 K	3.26 K	26.2 K	28.6 K	-	-	-	-	-	-	-
EBITDA	-18.9 M	-15.3 M	-14.5 M	-9.44 M	-3.83 M	-7.35 M	-	-	-	-	-	-	-
Operating Expenses	18.9 M	15.3 M	14.5 M	9.45 M	3.83 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	4.77 M	5.97 M	4.68 M	4.39 M	1.98 M	861 K	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement CNS Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	22.2 M	377 K	8.71 M	124 K	83.5 K	77.5 K	1.91 M	1.62 M	1.33 M	1.33 M	1.29 M	27.9 M	27.4 M	25.4 M	24.7 M	23.9 M	16.5 M	16.5 M	16.5 M	16.5 M	13.6 M	13.2 M	12.7 M	16.5 M	10.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.61 M	-2.53 M	-3.54 M	-	-4.52 M	-4.02 M	-4.93 M	-	-3.42 M	-3.57 M	-3.15 M	-	-3.81 M	-3.81 M	-3.61 M	-	-2.01 M	-2.47 M	-1.97 M	-	-707 K	-432 K	-212 K	-	-193 K	-257 K	-310 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	76.1 K	65.8 K	48.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.63 M	-2.53 M	-3.54 M	-	-4.53 M	-4.03 M	-4.93 M	-	-3.42 M	-3.56 M	-3.15 M	-	-3.81 M	-3.81 M	-3.61 M	-	-2.01 M	-2.47 M	-1.97 M	-	-699 K	-415 K	-195 K	-	-170 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	6.62 K	-	1.84 K	3.65 K	5.44 K	-	538	1.61 K	2.57 K	-	947	2.35 K	3.75 K	-	-	-	-	-	7.56 K	7.48 K	7.49 K	-	10.6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-3.54 M	-	-	-	-4.93 M	-	-3.41 M	-3.56 M	-3.15 M	-	-3.8 M	-3.81 M	-3.61 M	-	-2 M	-2.47 M	-1.97 M	-	-698 K	-415 K	-195 K	-	-170 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	5.63 M	2.53 M	3.54 M	-	4.53 M	4.03 M	4.93 M	-	3.42 M	3.56 M	3.15 M	-	3.81 M	3.81 M	3.61 M	-	2.01 M	2.47 M	1.97 M	-	699 K	415 K	195 K	-	170 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.38 M	1.41 M	1.11 M	-	1.12 M	1.18 M	1.36 M	-	1.21 M	1.34 M	1.26 M	-	1.24 M	1.15 M	1.4 M	-	969 K	981 K	1.36 M	-	373 K	372 K	147 K	-	165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency